Latest News JenaValve Announces LateBreaking Data from the ALIGNAR Businessfortnight

IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from the ALIGN-AR Pivotal Trial for the Trilogy THV System in high-risk patients with symptomatic, severe aortic regurgitation (AR). The trial met prespecified non-inferiority criteria…Read More